The Motley Fool

Here’s why this Nick Train-backed FTSE 250 share is suffering today

Image source: Getty Images

Fund manager Nick Train has built up a reputation for being one of the best in the business. A committed ‘quality’ investor, Train buys shares in companies with the intention of holding them for the very, very long term.

Unsurprisingly, the market always takes notice when he takes a new position. This is what happened last year when he bought soap maker and FTSE 250 member PZ Cussons (LSE: PZC).

5G is here – and shares of this ‘sleeping giant’ could be a great way for you to potentially profit!

According to one leading industry firm, the 5G boom could create a global industry worth US$12.3 TRILLION out of thin air…

And if you click here we’ll show you something that could be key to unlocking 5G’s full potential...

Today, the shares are down over 6% following a trading update for the first quarter of its financial year. What on earth is wrong?

FTSE 250 recovery play

Actually, not all that much. Today, PZ reported a 23% rise in revenue to £158.1m in the three months to the end of August compared to the same period in 2019. Unsurprisingly, these results were partly driven by “strong demand” for its hygiene brands, such as Carex.

Growth in its European and the American markets was particularly strong. Collectively, revenue here grew by 49% to £61.5m, thanks to all that handwashing and sanitising we’ve been doing. That said, sales of its most recognisable brands, Imperial Leather and Original Source, declined. 

Elsewhere, revenue from PZ’s Asia Pacific and Africa regions rose 9% and 4% at constant currency respectively. Signs that sales in important markets such as Australia and Nigeria were recovering was particularly encouraging.

No, PZ’s share price tumble appears to be down to the cautious tone of CEO Jonathan Myers.

Cautious tone

Commenting on today’s numbers, Myers said that PZ’s operating landscape “remains highly volatile” for three reasons.

First, many of the economies in which the company operates are either in, or shortly to be in, recession. Clearly, this could impact on consumption of the company’s products as people tighten the purse strings.

Second, the trajectory of the virus remains uncertain, thereby making it hard for the business to provide guidance on earnings.

Third, the markets in which PZ operates — personal healthcare and consumer goods — will continue to be highly competitive. No surprise there.

Taking all this into account, Myers expects “some adverse headwinds for the rest of the year.” Perhaps the share price drop makes sense after all.

So, are the shares a buy?

PZ Cussons was trading on 19 times forecast earnings before markets opened this morning. Whether this represents good value or not is tricky to say. 

On the one hand, it’s possible that the psychological impact of the coronavirus will remain long after the bug is gone. This bodes well for the mid-cap given its self-proclaimed “clear leadership” of the UK hand sanitiser market.

I also like that PZ isn’t overly dependent on one region or country for sales and that it’s talked of making progress in reducing its debt burden.

On the other hand, you might argue that demand for its hygiene products is already reflected in the valuation and the emergence of a vaccine could mean a sharp reversal in sales.

Less committed, short-term traders may also be inclined to sell following news that the FTSE 250 member plans to increase investment in its brands over Q2.

Personally, I think there are far worse things to do with your money than buying PZ Cussons. However, if you don’t feel confident enough to do so right now, you could always opt for the LF Lindsell Train UK Equity Fund instead. 

5 Stocks For Trying To Build Wealth After 50

Markets around the world are reeling from the coronavirus pandemic…

And with so many great companies trading at what look to be ‘discount-bin’ prices, now could be the time for savvy investors to snap up some potential bargains.

But whether you’re a newbie investor or a seasoned pro, deciding which stocks to add to your shopping list can be daunting prospect during such unprecedented times.

Fortunately, The Motley Fool is here to help: our UK Chief Investment Officer and his analyst team have short-listed five companies that they believe STILL boast significant long-term growth prospects despite the global lock-down…

You see, here at The Motley Fool we don’t believe “over-trading” is the right path to financial freedom in retirement; instead, we advocate buying and holding (for AT LEAST three to five years) 15 or more quality companies, with shareholder-focused management teams at the helm.

That’s why we’re sharing the names of all five of these companies in a special investing report that you can download today for FREE. If you’re 50 or over, we believe these stocks could be a great fit for any well-diversified portfolio, and that you can consider building a position in all five right away.

Click here to claim your free copy of this special investing report now!

Paul Summers has no position in any of the shares mentioned. The Motley Fool UK has recommended PZ Cussons. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.